V

VistaGen Therapeutics
D

VTGN

3.07000
USD
0.36
(13.28%)
مغلق
حجم التداول
17,742
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
89,514,240
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
A
APVO
-0.18000
(-5.56%)
3.06000 USD
C
CLDX
0.110
(0.47%)
23.360 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
M
MNKD
-0.02500
(-0.61%)
4.05000 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
S
SUPN
0.740
(2.25%)
33.600 USD
T
TBPH
-0.072
(-0.65%)
11.050 USD
المزيد
الأخبار المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.